ScreenerHero

NANOFHNanoform Finland Oyj

HEL · FI · Healthcare · Biotechnology · nanoform.com
0.9550EUR+4.95%Mkt Cap: 89.02M $P/E: —

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap89.02M $
Enterprise Value74.08M $
Revenue (TTM)5.89M $
Gross Profit3.31M $
Net Income (TTM)-19.45M $
Revenue/Share0.0696 USD
Last Price0.9550 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees139
CountryFI
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972
Valuation
P/E (Trailing)—
P/E (Forward)-7.51
PEG—
EV/EBITDA-4.08
EV/Revenue12.57
P/S14.86
P/B2.02
EPS (TTM)-0.19
EPS (Forward)-0.13
52W Range
0.377058% of range1.382
52W High1.382 EUR
52W Low0.3770 EUR
Profitability
Gross Margin85.82%
Oper. Margin-262.56%
EBITDA Margin0.00%
Profit Margin-504.74%
ROE-41.84%
ROA-33.16%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.20M $
CapEx (TTM)1.24M $
FCF Margin-205.15%
FCF Yield-13.58%
Net Debt-15.41M $
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.15
Current Ratio4.01
Quick Ratio3.79
Book Value/Sh0.4640 EUR
Cash/Share0.2400 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.125 EUR
Upside (mean)+122.5%
Target Range2.000 EUR – 2.250 EUR
€2.000+122.5% to mean€2.250
# Analysts2
Ownership
Shares Out.85.75M
Float24.60M
Insiders23.28%
Institutions38.27%
Technical
SMA 500.8654 (+10.4%)
SMA 2000.8413 (+13.5%)
Beta0.78
S&P 52W Chg18.16%
Avg Vol (30d)75.70K
Avg Vol (10d)103.60K
Technical Indicators
RSI (14)55.1
MACD0.0327
MACD Signal0.0392
MACD Hist.-0.0066
BB Upper1.063 EUR
BB Middle0.9415 EUR
BB Lower0.8200 EUR
BB Width25.80%
ATR (14)0.0477 EUR
Vol Ratio (20d)0.71x